


NanoValent Pharmaceuticals Revenue
Biotechnology Research • Bozeman, Montana, United States • 1-10 Employees
NanoValent Pharmaceuticals revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | $510,000 |
Key Contact at NanoValent Pharmaceuticals
Mark Lewis
Chief Executive Officer
Company overview
| Headquarters | 351 b Evergreen Dr, Bozeman, Montana 59715, US |
| Phone number | +14065868420 |
| Website | |
| SIC | 283 |
| Founded | 2006 |
| Employees | 1-10 |
| Socials |
NanoValent Pharmaceuticals Email Formats
NanoValent Pharmaceuticals uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@nanovalent.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@nanovalent.com | 100% |
About NanoValent Pharmaceuticals
NanoValent Pharmaceuticals, Inc. is a pharmaceutical company developing a new nano-particle based TNS (Targeted NanoSpheres) technology to create and develop novel cancer therapies
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
NanoValent Pharmaceuticals has 1 employees across 1 departments.
Departments
Number of employees
NanoValent Pharmaceuticals Tech Stack
Discover the technologies and tools that power NanoValent Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
Maps
Analytics
JavaScript libraries
JavaScript libraries
Programming languages
Blogs
Analytics
UI frameworks
CDN
Tag managers
Frequently asked questions
4.8
40,000 users



